Literature DB >> 3372451

Stabilization of fibroblast growth factors by a non-cytotoxic zwitterionic detergent, 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS).

Y Matuo1, N Nishi, Y Muguruma, Y Yoshitake, Y Masuda, K Nishikawa, F Wada.   

Abstract

The potential usefulness of a zwitterionic detergent, 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHPAS), in the stabilization of acidic and basic fibroblast growth factors (FGFs) was examined. Among several detergents, CHAPS was found to be not only non-cytotoxic but also most useful in handling the diluted preparations of FGFs. The advantages are as follows: 1) at lower concentrations than 0.01% CHAPS did not affect growth factor activity of calf serum (CS) and the growth rate of BALB/c 3T3 cells. The primary culture of rat prostate epithelium and colony formation of NRK-49F cells were hardly influenced by CHAPS lower than 0.003%; 2) the loss of FGFs that usually occurs due to their adherence to the surface of storage containers was effectively prevented by inclusion of 0.1% CHAPS; 3) the recovery of FGFs after storage or dialysis was significantly enhanced by inclusion of 0.1% CHAPS; 4) CHAPS at lower concentrations than 0.1% does not interfere with amino acid analysis, except that Thr may be misled only when the ratio of protein/CHAPS is low; 5) amino acid sequence analysis was hardly disturbed by CHAPS up to 0.5%. These results indicate that CHAPS is useful as a stabilizing agent for various kinds of polypeptides capable of showing biological activity at a low concentration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372451     DOI: 10.1007/bf02628502

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  11 in total

1.  A human prostatic growth factor (hPGF): partial purification and characterization.

Authors:  N Nishi; Y Matuo; Y Muguruma; Y Yoshitake; K Nishikawa; F Wada
Journal:  Biochem Biophys Res Commun       Date:  1985-11-15       Impact factor: 3.575

Review 2.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

3.  Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.

Authors:  F Esch; A Baird; N Ling; N Ueno; F Hill; L Denoroy; R Klepper; D Gospodarowicz; P Böhlen; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

Review 4.  Autocrine growth factors and cancer.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

5.  Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture.

Authors:  W L McKeehan; P S Adams; M P Rosser
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

6.  Rapid analysis of amino acids using pre-column derivatization.

Authors:  B A Bidlingmeyer; S A Cohen; T L Tarvin
Journal:  J Chromatogr       Date:  1984-12-07

7.  Proliferation of epithelial cells derived from rat dorsolateral prostate in serum-free primary cell culture and their response to androgen.

Authors:  N Nishi; Y Matuo; T Nakamoto; F Wada
Journal:  In Vitro Cell Dev Biol       Date:  1988-08

8.  Heparin binding affinity of rat prostatic growth factor in normal and cancerous prostates: partial purification and characterization of rat prostatic growth factor in the Dunning tumor.

Authors:  Y Matuo; N Nishi; S Matsui; A A Sandberg; J T Isaacs; F Wada
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

9.  Solubilization and purification of rat liver 5'-nucleotidase by use of a zwitterionic detergent and a monoclonal-antibody immunoadsorbent.

Authors:  E M Bailyes; A C Newby; K Siddle; J P Luzio
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

10.  Detergent solubilization of the interleukin 1 receptor.

Authors:  K A Paganelli; A S Stern; P L Kilian
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

View more
  9 in total

1.  Characterization of release of basic fibroblast growth factor from bovine retinal endothelial cells in monolayer cultures.

Authors:  R A Brooks; J M Burrin; E M Kohner
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Can fibroblast growth factors substitute for bovine pituitary extracts in culture systems for hair apparatus cells?

Authors:  N Tanigaki-Obana; M Ito
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

3.  The androgen-dependent rat prostate protein, probasin, is a heparin-binding protein that co-purifies with heparin-binding growth factor-1.

Authors:  Y Matuo; P S Adams; N Nishi; H Yasumitsu; J W Crabb; R J Matusik; W L McKeehan
Journal:  In Vitro Cell Dev Biol       Date:  1989-06

4.  The usefulness of CHAPS as a non-cytotoxic stabilizing agent in purification of growth factors.

Authors:  Y Matuo; N Nishi; Y Muguruma; Y Yoshitake; Y Masuda; K Nishikawa; F Wada
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

5.  Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury.

Authors:  R R Padua; R Sethi; N S Dhalla; E Kardami
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

6.  Species-specific differences in the mitogenic activity of heparin-binding growth factors in the sera of various mammals.

Authors:  Y Yonezawa; H Kondo; R Hirai; K Kaji; K Nishikawa
Journal:  Experientia       Date:  1992-03-15

7.  Production of IGF-II-related peptide by an anaplastic cell line (AT-3) established from the Dunning prostatic carcinoma of rats.

Authors:  Y Matuo; N Nishi; H Tanaka; I Sasaki; J T Isaacs; F Wada
Journal:  In Vitro Cell Dev Biol       Date:  1988-10

8.  Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.

Authors:  K Matsuzaki; Y Yoshitake; Y Matuo; H Sasaki; K Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Production of basic fibroblast growth factor-like factor by cultured human cholangiocellular carcinoma cells.

Authors:  K Matsuzaki; Y Yoshitake; M Miyagiwa; M Minemura; M Tanaka; H Sasaki; K Nishikawa
Journal:  Jpn J Cancer Res       Date:  1990-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.